Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

This Marvell ETF May Be Ready for Big Things

BY | ETF Database
5:25 am ET 10/14/26 | 21 VIEWS
Shares of Marvell Technology (MRVL), a rising player on the AI semiconductor stage, are higher by more than 21% for the month ending Oct. 9. It’s easy to understand why.Indicating that risk-aware, short-term traders may want to evaluate the Direxion Daily MRVL Bull 2X ETF (MRVU), Marvell updated its financial guidance. Management indicates it expects 58% annualized top-line growth through 2030. Underscoring the potential potency of MRVU, which attempts to deliver 200% of the daily performance of the tech stock, Marvell sees pathways to $90 billion in sales by fiscal 2031. “Marvell’s base case comes in more than 50% higher on the top and bottom lines in 2030 than our bullish model coming in,” noted Morningstar analyst William Kerwin. “It agrees with our view that artificial intelligence demand is accelerating through 2028 and durable through 2030. Still, the rate of growth blew our model out of the water.”AI Spending Supportive of Marvell, MRVUAs a provider of networking and processing chips into data centers, Marvell is very much tethered to AI spending. And the aforementioned increased guidance may be a sign that the company believes hyperscaler expenditures will be durable for at least a few more years. The AI spending road and Marvell’s own journey to revenue growth may not be bump-free. But for traders who can handle the risks of leveraged ETFs, occasional use of MRVU could be rewarding. “Marvell fully endorsed durable AI spending, calling for $3 trillion in AI capital spending in 2030 and supported by rising profitability and hyperscale cloud providers. We still see loss-making frontier labs OpenAI and Anthropic as material risks to this growth until they show they can turn a profit,” added Kerwin. There’s more to the Marvell story. And it’s potentially compelling news to traders considering sporadic use of the geared MRVU. The tech company has a deep product portfolio and a surprisingly diverse client base. That confirms it’s not tethered to a singular AI concept or demand from just one hyperscaler. “We like Marvell’s focus on connectivity, a wide product set, and a diverse customer base,” concluded Kerwin. “To us, it owns both depth and breadth across AI silicon infrastructure, despite being a relatively small compute player. We see management’s targets as highly credible.” Morningstar has a fair value estimate of $360 on Marvell, well ahead of its Oct. 9 closing price of $275.28. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

More Commentary

QQQI Hits 15 Billion Mark Aided by Tax-Efficient Approach
BY | ETF Database
5:23 am ET 10/14/26 | 26 VIEWS
This Duo Livens Up the Long/Short ETF Proposition
BY | ETF Database
6:06 am ET 10/14/26 | 15 VIEWS
Combining Growth Optimism With Fundamental Discipline
BY | ETF Database
6:47 am ET 10/14/26 | 12 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.